Beware of scams: Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

You can also contact A*STAR via our online form or call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Antibodies (resized)

Realise Quality Processes for Biomanufacturing

To align with EDB’s drive to expand the footprint of Singapore as a biopharma hub

Cells (resized)

Research Excellence

A centre of excellence for groundbreaking research in Proteins, Cells, and Nucleic Acids bioprocessing technologies

Partnership (resized)

Industry Collaboration

Cultivating partnerships with industry to advance innovations and translate research into industrial applications

Bioreactor (resized)

Talent Development

Providing development and training programmes to support biomanufacturing and research activities in Singapore

A*STAR Bioprocessing Technology Institute (BTI)

Who We Are

A*STAR Bioprocessing Technology Institute (BTI) focuses on advancing bioprocessing technologies and research over its 35-year history. Our current vision is to Realise Quality Processes for Biomanufacturing, with a strong emphasis on Proteins, Cells, and Nucleic Acids.

 

BTI’s Key Focus Areas

To achieve BTI’s vision of ensuring Quality Processes for Biomanufacturing, the institute develops innovative research capabilities and advanced biomanufacturing technologies. Modality-specific strategies are key to BTI achieving its mission of developing Singapore's biomanufacturing sector where asset classes are in various stages of maturity and development.

Read More

BTI Focus Area (PCN)

 

BTI's Core Capabilities

BTI’s core capabilities are systematically organised around its four principal divisions, which oversee 19 Enabling Research Groups, and Technology Platforms and Consortia. The matrix structure of BTI’s divisions enables the swift and flexible assembly of research teams with synergistic capabilities, allowing them to effectively address research and industry problem statements.

Read More

BTI Capabilities

 

Enabling the Next-Gen Tissue Membrane Factory

Growing living cells in a uniform three-dimensional (3D) membrane is valuable for many applications ranging from drug screening to cutting-edge cell and tissue-based therapies and potentially even for food applications such as cultivated meat. Conventional methods rely on complex printing equipment, which are costly and hard to scale up. Our multidisciplinary groups at BTI have developed a simple yet effective spheroid-sheet method that guides small cell spheroids, each containing thousands of living cells, to merge into a large and thin tissue membrane. By mimicking nature’s cell-packing strategy, we make the large-scale, consistent production of tissue membranes more achievable.

Read more: https://www.a-star.edu.sg/bti/bti-research-highlights/enabling-the-next-gen-tissue-membrane-factory